X4 Pharmaceuticals, Inc.

Company ID 605289213 Status Active

X4 Pharmaceuticals, Inc. was incorporated as a Foreign For-profit Corporation on July 10, 2023, with its office address at 61 North Beacon St Fl 4, Boston, MA 02134-1912, United States and mailing address at "61 North Beacon St Fl 4, Boston, MA 02134-1912, United States". It is registered with the Delaware Division of Corporations and is authorized to conduct business in Washington. United Agent Group INC serves as the registered agent. The company's directors are Paula Ragan, Adam Mostafa and Mark Baldry and three others. The company is currently active. It has been operating for 1 year, 9 months and 12 days.

Contact

Mail Address

61 North Beacon St Fl 4, Boston, MA 02134-1912, United States

[email protected]

Telephone

Website

Go to website

Social Media

Basic Information

Updated: 2025-03-17

Company Name

X4 Pharmaceuticals, Inc.

Company ID

605289213

Date of Registration

2023-07-10

Agent Information

Agent Name: United Agent Group Inc

Address: 707 W. Main Avenue #b1, Spokane, WA 99201, United States

Governing Persons

Officer/People

Name	Title
Paula Ragan Address: None	Governor
Adam Mostafa Address: None	Governor
Mark Baldry Address: None	Governor
William Aliski Address: None	Governor
Alison Lawton Address: None	Governor
Francoise De Craecker Address: None	Governor

Paula Ragan

Address: None

Title

Governor

Adam Mostafa

Address: None

Title

Governor

Mark Baldry

Address: None

Title

Governor

William Aliski

Address: None

Title

Governor

Alison Lawton

Address: None

Title

Governor

Francoise De Craecker

Address: None

Title

Governor

Gain a complete understanding of who truly controls a company by exploring its PSC (Persons with Significant Control), shareholders, and group structure.
*This section is pending updates and revisions.

Gain a complete understanding of who truly controls a company by exploring its PSC (Persons with Significant Control), shareholders, and group structure.

*This section is pending updates and revisions.